anti-CD30 chimeric antigen receptor T cells (CAR-T)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-CD30 chimeric antigen receptor T cells (CAR-T), covering 2022-05-25 to 2022-05-25. Get the full timeline:
Most recent: Clinical Trial Update: T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas [Phase 1]